On February 28, AACC urged the FDA to permit qualified labs to build and use laboratory developed tests (LDTs) to detect the novel coronavirus. Just three days later, the FDA changed its policy to allow these LDTs. When AACC speaks — to the FDA, the HHS, the Coronavirus Task Force, and Congress — policy for public health improves.

AACC leaders have shared their lab expertise on Good Morning America, CNN, NPR, and other outlets. Our COVID-19 resources and positions have been covered in The Washington Post, The Wall Street Journal, The New York Times, The Los Angeles Times, ABC News, Vanity Fair, National Journal, and elsewhere. And our lab experts have kept the public informed by answering common questions about testing.